🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Are some people more susceptible to placebos? DOI: doi.org/10.1016/j.jpai… 🙏 Co-authors: Daniel Belavy A/Prof Patrick J Owen @HugoPedder Svenja Ka Lars Donath Dr Clint Miller

Why are weight loss drugs like semaglutide making headlines for managing knee #osteoarthritis? 🤔 This week on The Joint Action Podcast 🦴, we dive into the groundbreaking research with Prof. Henning Bliddal. Tune in to the findings that could redefine OA treatment: open.spotify.com/episode/37rjQL…

Identification of latent classes of randomized controlled trials based on integrity and reporting characteristics. pubmed.ncbi.nlm.nih.gov/39694301/

🧵 Thrilled to share our new paper with Adriani Nikolakopoulou, Svenja Ka, Daniel Belavy, and A/Prof Patrick J Owen in BMJ Open Sport & Exercise Medicine, where we provide practical guidance on improving Network Meta-Analysis (NMA) in Sport & Exercise Medicine (SEM). A quick breakdown: bmjopensem.bmj.com/content/10/4/e…

Healthy Lifestyle Care vs Guideline-Based Care for Low Back Pain: A Randomized Clinical Trial 👇👇👇 pubmed.ncbi.nlm.nih.gov/39792385/

When Institute for Musculoskeletal Health began studying LBP in ED setting we got told it was just an Australian thing. Turns out it is also a German thing. pubmed.ncbi.nlm.nih.gov/39806647/

This network meta-analysis provides low to moderate certainty evidence that, compared with sham procedures, commonly performed interventional procedures for axial or radicular chronic non-cancer spine pain may provide little to no pain relief bmj.com/content/388/bm…

⏰ This month's #EditorsChoice is on Acetabular Dysplasia (AD) 🧐 In 18,807 hips over 4-8 years ➡️ AD increased the odds of developing hip osteoarthritis by 80%! Read for free from Riedstra et al - oarsijournal.com/article/S1063-… World COACH consortium

Just published in BJSM 🔥 Efficacy of cognitive functional therapy for pain intensity and disability in patients with NSLBP 👉"CFT showed sustained clinical efficacy compared with a sham procedure for treating patients with NSLBP." bjsm.bmj.com/content/early/…

🥳 Just out in March's issue! 🛑 Assuming regression to the mean (RTM) for real change? #caveatemptor Free to read from Martin Englund and Turkiewicz - oarsijournal.com/action/showPdf…

Systematic reviews with network meta-analysis have potential biases in their conduct, analysis, and interpretation. A new tool helps to assess these risk of bias for healthcare interventions. Read the guidance article Carole Lunny bmj.com/content/388/bm…

Instruments assessing risk of bias in randomised trials have often focused on methodological rigour at the expense of practicability. This new tool allows users to assess risk of bias of RCTs included in systematic reviews in a user friendly way bmj.com/content/388/bm…

Original Article: Global Effect of Cardiovascular Risk Factors on Lifetime Estimates nej.md/4kS5ZVr #ACC25 | American College of Cardiology

Inclusion of Retracted Studies in Systematic Reviews and Meta-Analyses of Interventions jamanetwork.com/journals/jamai…

Risk factors for the development of knee osteoarthritis across the lifespan: a systematic review and meta-analysis pubmed.ncbi.nlm.nih.gov/40174718/

Review: A meta-analysis conducted by Tobias Saueressig, Dr. Daniel Belavy et al. found little evidence of distinct placebo responders in musculoskeletal pain, though individual responses vary. Full: jpain.org/article/S1526-…

Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity jamanetwork.com/journals/jama/…

Input needed from clinical researchers and methodologists who have knowledge of patient reported outcomes, minimum clinically important differences, and possibly change vs absolute status: discourse.datamethods.org/t/challenges-i…

This updated SPIRIT 2025 (Standard Protocol Items: Recommendations for Interventional Trials) explanation and elaboration document provides guidance on protocols of randomised trials for researchers bmj.com/content/389/bm…

Original Article: Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5 phase 3b trial) nej.md/44ZeMPz EASO | #ECO2025